PHARMANUTRA: REVENUES FOR THE FIRST HALF OF 2018 UP BY 20%. THE GROUP STRENGTHENS ITS INTERNATIONAL PRESENCE

Related News

• (Italiano) 151 Miglia – Trofeo Cetilar rimandata...

  Sorry, this entry is only available in Italian.

• Two news patents approved in India and US...

  The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL®...

Related Products

• SiderAL Forte

  Sideral is a nutritional supplement that contains Sucrosomial® Iron (Sideral® r.m) and vitamin C,...

• (Italiano) ApportAL

  Sorry, this entry...